In 2025, over 200,000 Americans were diagnosed with skin cancer. Thankfully, five months ago, U.S. Dermatology Partners ...

Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...

The firm is looking ahead to Phase III Kimmtrak results in cutaneous melanoma and early-stage readouts from its PRAME candidates.

aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...

Dermatologists reveal the silent signs of skin cancer that are often overlooked, such as a pimple that doesn't go away. The ...

On November 11, 2025, CheckMySpot(R) , the Direct Access Platform(TM) for early skin cancer detection, was honored during the 2025 National Alliance of Healthcare Purchaser Coalitions Annual Forum ...

Loqtorzi (toripalimab) showed significant improvement in progression-free survival for acral melanoma compared to standard chemotherapy in a phase 3 trial. Acral melanoma, a rare and aggressive ...

After visiting her Hallmark bestie, Crystal Lowe, who's battling cancer, Kristin Booth is now facing her own diagnosis.

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the ...

A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...

Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...